Halozyme Therapeutics Inc. Common Stock vs Interactive Brokers Group Inc. Class A Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Interactive Brokers Group Inc. Class A Common Stock trades at $87.87 (market cap $39.18B). The key difference: Interactive Brokers Group Inc. Class A Common Stock is far larger — about 3.1× Halozyme Therapeutics Inc. Common Stock's market cap, and Interactive Brokers Group Inc. Class A Common Stock pays a 0.4% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Interactive Brokers Group Inc. Class A Common Stock for 1 Days on average.
| HALO | IBKR | |
|---|---|---|
Market Cap | $12.58B | $39.18B |
Volume | 2,179,278 | 2,996,599 |
Sector | Health | Financials |
52-Week High | $115.22 | $98.19 |
52-Week Low | $61.63 | $61.05 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $31.48B |
Dividend Yield | — | 0.4% |
Trailing returns across standard periods
Latest headlines on both assets
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Interactive Brokers operates an electronic brokerage platform for trading stocks, options, futures, currencies, and other assets. It also provides clearing and custody services.
Read more on IBKR →